Manipulating expression of the gene PTEN in cancer and the central nervous system with genetic and epigenetic editing

Colette Moses

Research output: Thesis › Doctoral Thesis

157 Downloads (Pure)

Abstract

Genetic or epigenetic loss of phosphatase and tensin homolog (PTEN) contributes to the initiation, progression and drug resistance of many human cancers. However, PTEN is strongly expressed in central nervous system (CNS) neurons, and inhibits their ability to survive and regenerate axons to restore functional connections after traumatic brain or spinal cord injury, stroke or neurodegenerative disease. This research developed genetic and epigenetic editing tools to restore expression of PTEN in cancer cells where the gene was transcriptionally repressed or mutated, and to silence PTEN expression in CNS neurons, with potential future applications for treatment of cancer and CNS regenerative failure.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • The University of Western Australia
Thesis sponsors
Award date25 Oct 2018
DOIs
Publication statusUnpublished - 2018

Access to Document

  • THESIS - DOCTOR OF PHILOSOPHY - MOSES Colette Kathryn - 2018

    This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.

    Fingerprint Dive into the research topics of 'Manipulating expression of the gene PTEN in cancer and the central nervous system with genetic and epigenetic editing'. Together they form a unique fingerprint.

    Cite this